GMP-compliant lipid nanoparticle automatic synthesis system Sunbather
Accelerating formulation optimization for vaccine and pharmaceutical development.
The transition from LNP to GMP is a costly and complicated process. Typically, this requires switching equipment, using different flow paths and mixing devices, and essentially re-developing and re-validating everything that has been painstakingly done so far. With Sunbather, the transition to GMP can be done easily thanks to its recording features, interchangeable flow paths, and easily transferable design. Sunbather uses the same mixing process and protocols as the Sunscreen and Sunshine from the same Sun series, allowing for easy transition of adjusted formulation conditions to GMP. - Up to 1.8 L/h - Integrated inline dilution - Fully interchangeable flow paths - A wide variety of mixing devices - Software compliant with 21 CFR Part 11 - Process transferable from Sunshine
basic information
Throughput: 10 mL/min per channel Total flow rate range: 0.1 to 30 mL/min (depending on configuration) Flow ratio (water to organic) range: 1:1 to 10:1 Standard sample volume range (when FRR is 3:1): 400 µL to 2 mL Inline dilution: Yes Standard particle size range: 40 to 200 nm (depending on formulation) PDI: Less than 0.2 (depending on formulation) Encapsulation efficiency: Over 90% (depending on formulation)
Price range
Delivery Time
Model number/Brand name
GMP-compliant lipid nanoparticle automatic synthesis system Sunbather
Applications/Examples of results
Pharmaceutical development Lipid nanoparticle production GMP manufacturing
catalog（9）
Download All Catalogs
News about this product（9）
-
[Free Webinar] Revolutionizing LNP Development: Smooth Technology Transfer for High-Speed and High-Precision Formulation Exploration and Manufacturing
**[Issue]** The evolution of LNPs is progressing more rapidly than ever, largely due to modifications in particle formulations. However, the formulations to be tested are complex in composition and involve a vast number of combinations, making large-scale screening difficult to achieve. Furthermore, there is the subsequent challenge of transferring to production. Evaluations are also required to be accurate, comprehensive, and high-throughput. **[Webinar Overview]** In this webinar, we will explain how our Sun series can accelerate the exploration and development of LNPs, based on the latest research findings and user case studies in LNP formulations. We will also introduce Stunner, which enables high-speed and accurate LNP evaluations.
-
We will exhibit at the DDS Society academic conference.
Unchained Labs, Inc. will exhibit at the 41st Annual Meeting of the Japanese DDS Society, which will be held from June 17 (Tuesday). At our booth, you can see a wide range of products, from the manufacturing of lipid nanoparticles (LNP) to their characterization, as well as products for ADC and the evaluation of extracellular vesicles. Additionally, on the first day of the event, July 17, we will also hold a presentation by exhibiting companies. All of our staff sincerely look forward to your visit. Event Name: 41st Annual Meeting of the Japanese DDS Society Date: July 17 (Tuesday) - July 18 (Wednesday) Venue: Makuhari Messe International Conference Hall Details: https://procomu.jp/dds2025/ <Exhibiting Company Presentation> July 17 (Tuesday) around 15:28
-
CPhI Japan Exhibition & Seminar!
CPhI Japan Exhibition & Seminar! April 9 (Wednesday) - 11 (Friday) @ Tokyo Big Sight Unchained Labs, Inc. will be exhibiting in the biopharmaceutical zone at CPhI Japan this year as well. Additionally, we will hold a seminar on the second day! Please visit our booth at Tokyo Big Sight. <Exhibitor Seminar> Date and Time: April 10 (Thursday) 13:00-13:30 Venue: 5B "Stability Evaluation of Biopharmaceuticals - Towards a New Era of High-Speed and High-Throughput" *No prior reservation required, free of charge.
-
Exhibition at the Japanese Pharmaceutical Society & Luncheon Held!
Unchained Labs, Inc. will exhibit at the 39th Annual Meeting of the Japanese Society of Pharmaceutical Sciences, which will be held from May 23 (Thursday) to May 25 (Saturday). At our booth, you can see a wide range of products from the manufacturing to the characterization of lipid nanoparticles (LNP), covering both the development and manufacturing phases. Additionally, on the third day, we will hold a luncheon on the same topic. All of our employees sincerely look forward to your visit. Event Name: 39th Annual Meeting of the Japanese Society of Pharmaceutical Sciences Date: May 23 (Thursday) - May 25 (Saturday) Venue: Kobe International Conference Center Booth: #20 Details: https://procomu.jp/apstj2024/ <Luncheon Seminar> May 25 (Saturday) 12:15 - 13:15 Room 401 + 402 "Accelerating the Development of Lipid Nanoparticle Formulations: High-Throughput Manufacturing Condition Evaluation and Analytical Applications"
-
Interfex Week Tokyo Exhibition & Seminar!
<Announcement of Interphex Exhibition and Product Technology Seminars> Our company will be exhibiting at the Interphex BioPharmaceuticals EXPO again this year. Additionally, we will be presenting at product technology seminars on the first and second days of the exhibition! We invite you to come to Tokyo Big Sight. Exhibition Details: Name: Interphex Week Tokyo (26th Edition) Date: June 26 (Wednesday) - 28 (Friday), 2024 Venue: Tokyo Big Sight Booth: 46-17 (East Hall 6), diagonally across from Cytiva's booth Product Technology Seminar 1 "Solutions for Completely Mastering Lipid Nanoparticles (LNP)" ● June 26 (Wednesday) 11:40 - 12:10 ● Venue: Exhibitor Seminar Room 6 (East Hall 5) Product Technology Seminar 2 "How to Achieve Automation in Chemical Research" ● June 27 (Thursday) 12:30 - 13:00 ● Venue: Exhibitor Seminar Room 7 (East Hall 6)
